Circulating antibodies against the breast tumor marker GCDFP-15/gp17 in mammary carcinoma patients and in patients carrying benign breast conditions

International Journal of Cancer

Volumn 84, Issue 6, 1999, Pages 568-572

  Pasquinelli, Rosa ^a   Barba, Pasquale ^b   Capasso, Immacolata ^a   D'Aiuto, Massimiliano ^a   D'Aiuto, Giuseppe ^a   Anzisi, Anna Maria ^a   De Berardinis, Piergiuseppe ^c   Guardiola, John ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^c CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ANTIBODY; GLYCOPROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; TUMOR MARKER;

ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST DYSPLASIA; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ANTIBODIES, NEOPLASM; APOLIPOPROTEINS; APOLIPOPROTEINS D; BREAST NEOPLASMS; CARRIER PROTEINS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LYMPHATIC METASTASIS; MEMBRANE TRANSPORT PROTEINS; NEOPLASM CIRCULATING CELLS; RECOMBINANT PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032763106     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19991222)84:6<568::AID-IJC5>3.0.CO;2-G     Document Type: Article

References (30)

1. AKIYAMA, K. and KIMURA, H., Isolation of a new actin-binding protein from human seminal plasma. Biochim. biophys. Acta, 1040, 206-210 (1990).
2. AUTIERO, M., ABRESCIA, P. and GUARDIOLA, J., Interaction of seminal plasma proteins with cell surface antigens: presence of a CD4-binding glycoprotein in human seminal plasma. Exp. Cell Res., 197, 268-271 (1991).
3. AUTIERO, M., CAMMAROTA, G., FRIEDLEIN, A., ZULAUF, M., CHIAPPETTA, G., DRAGONE, V. and GUARDIOLA, J., A 17-kDa CD4-binding glycoprotein present in human seminal plasma and in breast tumor cells. Europ. J. Immunol., 25, 1461-1464 (1995).
4. AUTIERO, M., GAUBIN, M., MANI, J.C., CASTEJON, C., MARTIN, M., EL MARHOMY, S., GUARDIOLA, J. and PIATIER TONNEAU, D., Surface plasmon resonance analysis of gp17, a natural CD4 ligand from human seminal plasma inhibiting human immunodeficiency virus type-1 gp120-mediated syncytium formation. Europ. J. Biochem., 245, 208-213 (1997).
5. BOON, T., COULIE, P.G. and VAN DEN EYNDE, B., Tumor antigens recognized by T cells. Immunol. Today, 18, 267-271 (1997).
6. BRANDTZAEG, P., Mucosal immunity in the female genital tract. J. Reprod. Immunol., 36, 23-50 (1997).
7. CAPUTO, E., AUTIERO, M., MANI, J.C., BASMOCIOGULLARI, S., PIATIER TONNEAU, D. and GUARDIOLA, J., Differential antibody reactivity and CD4 binding of the mammary tumor marker protein GCDFP-15 from breast cyst and its counterparts from exocrine epithelia. Int. J. Cancer, 78, 76-85 (1998).
8. CAPUTO, E., CARRATORE, V., CIULLO, M., TIBERIO, C., MANI, J.-C., PIATIER-TONNEAU, D. AND GUARDIOLA, J. Biosynthesis and immunobiochemical characterization of gp17/GCDFP-15, a glycoprotein from seminal vesicles and from breast tumors, in HeLa cells and in P. pastoris yeast. Europ. J. Biochem., In press (1999).
9. FARGHALY, S.A., Tumor markers in gynecologic cancer. Gynecol. Obstet. Invest., 34, 65-72 (1992).
10. FIEL, M.I., CERNAIANU, G., BURSTEIN, D.E. and BATHEJA, N., Value of GCDFP-15 (BRST-2) as a specific immunocytochemical marker for breast carcinoma in cytologic specimens. Acta Cytol., 40, 637-641 (1996).
11. GALLI-STAMPINO, L., MEINJOHANNS, E., FRISCHE, K., MELDAL, M., JENSEN, T., WERDELIN, O. and MOURITSEN, S., T-cell recognition of tumor associated carbohydrates: the nature of the glycan moiety plays a decisive role in determining glycopeptide immunogenicity. Cancer Res. 57, 3214-3222 (1997).
12. HAAGENSEN, D.E., JR., Is cystic disease related to breast cancer? Amer. J. surg. Pathol., 15, 687-694 (1991).
13. HAAGENSEN, D.E., JR., DILLEY, W.G., MAZOUJIAN, G. and WELLS, S.A., JR., Review of GCDFP-15. An apocrine marker protein. Ann. N.Y. Acad. Sci., 586, 161-173 (1990).
14. HAAGENSEN, D.E., KELLY, D. and BODIAN, C.A., GCDFP-15 blood levels for stratification of risk of breast cancer development in women with active breast gross cystic disease. Breast, 6, 113-119 (1997).
15. HAHNEL, R. and HAHNEL, E., Expression of the PIP/GCDFP-15 gene and survival in breast cancer. Virchows Arch., 429, 365-369 (1996).
16. LUBIN, R., SCHLICHTHOLZ, B., TEILLAUD, J.L., GARAY, E., BUSSEL, A., WILD, C.P. and SOUSSI, T., p53 antibodies in patients with various types of cancer: assay, identification and characterization. Clin. Cancer Res., 1, 1463-1469 (1995).
17. MANNI, A., SANTEN, R.J., BOUCHER, A.E., LIPTON, A., HARVEY, H., DRAGO, J., ROHNER, T., HAAGENSEN, D., GLODE, M. and SANTNER, S.J., Evaluation of CEA and GCDFP-15 plasma level during hormonally induced cancer stimulation. Anticancer Res., 4, 141-144 (1984).
18. MAZOUJIAN, G., BODIAN, C., HAAGENSEN, D.E., JR. and HAAGENSEN, C.D., Expression of GCDFP-15 in breast carcinomas. Relationship to pathologic and clinical factors. Cancer, 63, 2156-2161 (1989).
19. MAZOUJIAN, G., PINKUS, G.S., DAVIS, S. and HAAGENSEN, D.E., JR., Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features. Amer. J. Pathol., 110, 105-112 (1983).
20. MESTECKY, J., The common mucosal immune system and current strategies for induction of immune responses in external secretions. J. clin. Immunol., 7, 265-276 (1987).
21. MIRELS, L., HAND, A.R. and BRANIN, H.J., Expression of gross cystic disease fluid protein-15/prolactin-inducible protein in rat salivary glands. J. Histochem. Cytochem., 46, 1061-1071 (1998).
22. MONTEAGUDO, C., MERINO, M.J., LAPORTE, N. and NEUMANN, R.D., Value of gross cystic disease fluid protein-15 in distinguishing metastatic breast carcinomas among poorly differentiated neoplasms involving the ovary. Hum. Pathol., 22, 368-372 (1991).
23. MURPHY, L.C., LEE WING, M., GOLDENBERG, G.J. and SHIU, R.P.C., Expression of the gene encoding a prolactin-inducible protein by human breast cancers in vivo: correlation with steroid receptor status. Cancer Res., 47, 4160-4164 (1987).
24. MYAL, Y., IWASIOW, B., COSBY, H., YARMILL, A., BLANCHARD, A., TSUYUKI, D., FRESNOZA, A., DUCKWORTH, M.L. and SHIU, R.P., Analysis of tissue-and hormone-specific regulation of the human prolactin-inducible protein/gross cystic disease fluid protein-15 gene in transgenic mice. J. mol. Endocrinol., 21, 217-223 (1998).
25. MYAL, Y., ROBINSON, D.B., IWASIOW, B., TSUYUKI, D., WONG, P. and SHIU, R.P., The prolactin-inducible protein (PIP/GCDFP-15) gene: cloning, structure and regulation. Mol. cell. Endocrinol., 80, 165-175 (1991).
26. NAIR, P.N. and SCHROEDER, H.E., Duct-associated lymphoid tissue (DALT) of minor salivary glands and mucosal immunity. Immunology, 57, 171-180 (1986).
27. PAGANI, A., SAPINO, A., EUSEBI, V., BERGNOLO, P. and BUSSOLATI, G., PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast. Virchows Arch., 425, 459-465 (1994).
28. SCHALLER, J., AKIYAMA, K., KIMURA, H., HESS, D., AFFOLTER, M. and RICKLI, E.E., Primary structure of a new actin-binding protein from human seminal plasma. Europ. J. Biochem., 196, 743-750 (1991).
29. SCHENKELS, L.C., SCHALLER, J., WALGREEN WETERINGS, E., SCHADEE EESTERMANS, I.L., VEERMAN, E.C. and NIEUW AMERONGEN, A.V., Identity of human extra parotid glycoprotein (EP-GP) with secretory actin binding protein (SABP) and its biological properties. Biol. Chem. Hoppe Seyler, 375, 609-615 (1994).
30. STOCKERT, E., JAGER, E., CHEN, Y.T., SCANLAN, M.J., GOUT, I., KARBACH, J., ARAND, M., KNUTH, A. and OLD, L.J., A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J. exp. Med., 187, 1349-1354 (1998).